arrow_back Back to App

Easier Access to Urgent-Use Medications in Hospitals

New rules make it easier for pharmacies to prepare and supply urgently needed medications to hospitals when pre-made products are unavailable. This aims to ensure patients get faster access to essential treatments, especially in emergencies or during drug shortages. It enhances the safety and availability of medical care.
Key points
Pharmacies can prepare drugs for hospitals without an individual prescription if urgently needed and pre-made drugs are unavailable.
Hospitals must confirm urgent need and drug unavailability, and report which patients received the medication.
Pharmacists must report any adverse events related to compounded drugs, increasing patient safety.
Provisions also cover drugs in short supply, aiming to prevent treatment interruptions.
article Official text account_balance Process page
Expired
Citizen Poll
No votes cast
Additional Information
Print number: 118_HR_167
Sponsor: Rep. Griffith, H. Morgan [R-VA-9]
Process start date: 2023-01-09
Lustra uses Artificial Intelligence. Verify details in source documents.
Summarized by: gemini-2.5-flash-preview-05-20
Source data: api.congress.gov
AI work logs for this document launch

OFFICIAL LEGAL TITLE

Patient Access to Urgent-Use Pharmacy Compounding Act of 2023

FREQUENTLY ASKED QUESTIONS

What is the official ID of this bill?

The official print number for this legislation is 118_HR_167.

Which chamber initiated this legislation?

This legislation was initiated in the House of Representatives.

When did the legislative process begin?

The process officially started on 2023-01-09.

What are the main provisions?

Key points include:

  • Pharmacies can prepare drugs for hospitals without an individual prescription if urgently needed and pre-made drugs are unavailable.
  • Hospitals must confirm urgent need and drug unavailability, and report which patients received the medication.
  • Pharmacists must report any adverse events related to compounded drugs, increasing patient safety.
  • Provisions also cover drugs in short supply, aiming to prevent treatment interruptions.
What is the specific legal status?

The current status is Expired.

Where can I read the full text of this legislation?

The full official text is available at: View full text

Who is the primary sponsor?

The primary sponsor is Rep. Griffith, H. Morgan [R-VA-9].

What is the latest detailed status?

The latest detailed status is: Referred to the Subcommittee on Health.

Is this summary verified?

Yes. This content was analyzed by AI and verified by the Lustra Judge System on 2025-12-24.

CATEGORIES

Health